Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) is currently trading at 1,140.75 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Yatharth Hospital & Trauma Care Services Limited operates a network of super‑speciality tertiary and quaternary hospitals concentrated in the Delhi NCR and select North Indian markets, delivering complex specialties such as oncology, cardiology, neurosciences, robotic surgeries and organ transplants across eight hospitals and a reported bed capacity above 2,550 as of Q3 FY26. Q3 FY26 was the company’s strongest quarter with revenue of Rs.3,205 million (+46% YoY) and EBITDA of Rs.742 million; management reports an adjusted EBITDA margin of 29.2% excluding ramp‑up losses from New Delhi and Faridabad Sec‑20, indicating meaningful operating leverage from ARPOB gains and higher super‑speciality mix. The company has been acquisitive and capital intensive: Agra was acquired for Rs.260 crore and integrated from February 2026, while management has outlined a ~Rs.1,500 crore capex plan to reach ~5,000 beds using mixed models, implying capex per bed of roughly Rs.60–90 lakh depending on asset intensity and asset‑light share. Operational metrics are improving: blended occupancy stood at 67% and ARPOB at Rs.33,744 in Q3 FY26, supported by Noida Extension’s Rs.44k ARPOB; management is also building medical value travel channels and expects Jewar airport to enhance cross‑border patient flows, creating a non‑domestic growth vector.

Over the past 52 weeks, Yatharth Hospital & Trauma Care Services Ltd has traded between a low of ₹538.15 and a high of ₹1,183.15. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Yatharth Hospital & Trauma Care Services Ltd has a market capitalization of approximately 10,991.62. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Yatharth Hospital & Trauma Care Services Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 63.01 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 10,991.62 Cr, Yatharth Hospital & Trauma Care Services Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Yatharth Hospital & Trauma Care Services Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Yatharth Hospital & Trauma Care Services Ltd is 63.01. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

A preferential issue to Rasmalai Limited of equity shares and warrants for up to ₹3,150.00 crore, plus an increase in authorised share capital from ₹115 crore to ₹150 crore.

The shares rose after Yatharth disclosed an exchange filing stating Advent International signed a definitive agreement to invest Rs 3,150 crore as primary capital for an expected 24.9% stake.

The company disclosed that the hospital asset acquisition in Sector 40, Gurugram was completed on June 12, 2026.

Standalone net sales (income from operations) were ₹163.87 crore in Q4 FY26, up from ₹111.99 crore in Q4 FY25.